Titre : Voyage

Voyage : Questions médicales fréquentes

Termes MeSH sélectionnés :

Platelet Transfusion
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Voyage : Questions médicales les plus fréquentes", "headline": "Voyage : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Voyage : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-02", "dateModified": "2025-04-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Voyage" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Activités humaines", "url": "https://questionsmedicales.fr/mesh/D006802", "about": { "@type": "MedicalCondition", "name": "Activités humaines", "code": { "@type": "MedicalCode", "code": "D006802", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I03" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Voyage aérien", "alternateName": "Air Travel", "url": "https://questionsmedicales.fr/mesh/D064870", "about": { "@type": "MedicalCondition", "name": "Voyage aérien", "code": { "@type": "MedicalCode", "code": "D064870", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I03.883.209" } } }, { "@type": "MedicalWebPage", "name": "Expéditions", "alternateName": "Expeditions", "url": "https://questionsmedicales.fr/mesh/D005101", "about": { "@type": "MedicalCondition", "name": "Expéditions", "code": { "@type": "MedicalCode", "code": "D005101", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I03.883.532" } } }, { "@type": "MedicalWebPage", "name": "Tourisme", "alternateName": "Tourism", "url": "https://questionsmedicales.fr/mesh/D000085926", "about": { "@type": "MedicalCondition", "name": "Tourisme", "code": { "@type": "MedicalCode", "code": "D000085926", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I03.883.694" } } }, { "@type": "MedicalWebPage", "name": "Maladie liée aux voyages", "alternateName": "Travel-Related Illness", "url": "https://questionsmedicales.fr/mesh/D000076082", "about": { "@type": "MedicalCondition", "name": "Maladie liée aux voyages", "code": { "@type": "MedicalCode", "code": "D000076082", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I03.883.855" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Syndrome du décalage horaire", "alternateName": "Jet Lag Syndrome", "url": "https://questionsmedicales.fr/mesh/D020179", "about": { "@type": "MedicalCondition", "name": "Syndrome du décalage horaire", "code": { "@type": "MedicalCode", "code": "D020179", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "I03.883.855.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Voyage", "alternateName": "Travel", "code": { "@type": "MedicalCode", "code": "D014195", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Krzysztof Korzeniewski", "url": "https://questionsmedicales.fr/author/Krzysztof%20Korzeniewski", "affiliation": { "@type": "Organization", "name": "Department of Epidemiology and Tropical Medicine; Military Institute of Medicine, Warsaw, Poland. kkorzeniewski@wim.mil.pl." } }, { "@type": "Person", "name": "Lin H Chen", "url": "https://questionsmedicales.fr/author/Lin%20H%20Chen", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases and Travel Medicine, Mount Auburn Hospital, Cambridge, MA USA." } }, { "@type": "Person", "name": "Gerard T Flaherty", "url": "https://questionsmedicales.fr/author/Gerard%20T%20Flaherty", "affiliation": { "@type": "Organization", "name": "School of Medicine, National University of Ireland, Galway, Ireland." } }, { "@type": "Person", "name": "Christoph Lübbert", "url": "https://questionsmedicales.fr/author/Christoph%20L%C3%BCbbert", "affiliation": { "@type": "Organization", "name": "Medizinische Klinik II (Bereich Infektiologie und Tropenmedizin) des Universitätsklinikums Leipzig." } }, { "@type": "Person", "name": "Watcharapong Piyaphanee", "url": "https://questionsmedicales.fr/author/Watcharapong%20Piyaphanee", "affiliation": { "@type": "Organization", "name": "Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation.", "datePublished": "2023-01-20", "url": "https://questionsmedicales.fr/article/36599813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ejh.13925" } }, { "@type": "ScholarlyArticle", "name": "Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.", "datePublished": "2022-12-01", "url": "https://questionsmedicales.fr/article/36454598", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/vox.13387" } }, { "@type": "ScholarlyArticle", "name": "The safety of ABO minor incompatible platelets transfusions using a rapid infuser.", "datePublished": "2024-02-01", "url": "https://questionsmedicales.fr/article/38299721", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/trf.17739" } }, { "@type": "ScholarlyArticle", "name": "Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.", "datePublished": "2023-02-09", "url": "https://questionsmedicales.fr/article/36758527", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000529542" } }, { "@type": "ScholarlyArticle", "name": "Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.", "datePublished": "2022-11-12", "url": "https://questionsmedicales.fr/article/36369934", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/trf.17184" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Activités humaines", "item": "https://questionsmedicales.fr/mesh/D006802" }, { "@type": "ListItem", "position": 3, "name": "Voyage", "item": "https://questionsmedicales.fr/mesh/D014195" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Voyage - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Voyage", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Voyage", "description": "Comment diagnostiquer le paludisme chez un voyageur ?\nQuels tests pour la dengue après un voyage ?\nComment identifier une infection à Zika ?\nQuels signes indiquent une infection alimentaire ?\nComment diagnostiquer le choléra ?", "url": "https://questionsmedicales.fr/mesh/D014195?mesh_terms=Platelet+Transfusion&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Voyage", "description": "Quels symptômes du paludisme à surveiller ?\nQuels signes de la dengue sont préoccupants ?\nQuels symptômes de l'infection à Zika ?\nQuels symptômes d'une infection alimentaire ?\nQuels signes indiquent le choléra ?", "url": "https://questionsmedicales.fr/mesh/D014195?mesh_terms=Platelet+Transfusion&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Voyage", "description": "Comment prévenir le paludisme en voyage ?\nQuelles mesures pour éviter la dengue ?\nComment se protéger contre le virus Zika ?\nQuelles précautions pour éviter les infections alimentaires ?\nComment prévenir le choléra ?", "url": "https://questionsmedicales.fr/mesh/D014195?mesh_terms=Platelet+Transfusion&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Voyage", "description": "Quel traitement pour le paludisme ?\nComment traiter la dengue ?\nQuel traitement pour l'infection à Zika ?\nComment traiter une infection alimentaire ?\nQuel traitement pour le choléra ?", "url": "https://questionsmedicales.fr/mesh/D014195?mesh_terms=Platelet+Transfusion&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Voyage", "description": "Quelles complications du paludisme ?\nQuelles complications de la dengue ?\nQuelles complications de l'infection à Zika ?\nQuelles complications des infections alimentaires ?\nQuelles complications du choléra ?", "url": "https://questionsmedicales.fr/mesh/D014195?mesh_terms=Platelet+Transfusion&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Voyage", "description": "Quels sont les facteurs de risque du paludisme ?\nQuels facteurs augmentent le risque de dengue ?\nQuels facteurs de risque pour le virus Zika ?\nQuels facteurs de risque pour les infections alimentaires ?\nQuels facteurs de risque pour le choléra ?", "url": "https://questionsmedicales.fr/mesh/D014195?mesh_terms=Platelet+Transfusion&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le paludisme chez un voyageur ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic de paludisme se fait par un test sanguin pour détecter le parasite." } }, { "@type": "Question", "name": "Quels tests pour la dengue après un voyage ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Un test sérologique ou PCR peut confirmer une infection par le virus de la dengue." } }, { "@type": "Question", "name": "Comment identifier une infection à Zika ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Un test sanguin ou urinaire peut détecter le virus Zika après exposition." } }, { "@type": "Question", "name": "Quels signes indiquent une infection alimentaire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des vomissements, diarrhée et douleurs abdominales peuvent indiquer une infection." } }, { "@type": "Question", "name": "Comment diagnostiquer le choléra ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le choléra est diagnostiqué par l'isolement de Vibrio cholerae dans les selles." } }, { "@type": "Question", "name": "Quels symptômes du paludisme à surveiller ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons, sueurs, maux de tête et douleurs musculaires sont des symptômes clés." } }, { "@type": "Question", "name": "Quels signes de la dengue sont préoccupants ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, douleurs articulaires, éruptions cutanées et saignements peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes de l'infection à Zika ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, éruptions cutanées, douleurs articulaires et conjonctivite sont fréquents." } }, { "@type": "Question", "name": "Quels symptômes d'une infection alimentaire ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent nausées, vomissements, diarrhée et douleurs abdominales." } }, { "@type": "Question", "name": "Quels signes indiquent le choléra ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Diarrhée aqueuse sévère, déshydratation rapide et crampes abdominales sont typiques." } }, { "@type": "Question", "name": "Comment prévenir le paludisme en voyage ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des moustiquaires, des répulsifs et prenez des antipaludiques en prévention." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la dengue ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les piqûres de moustiques, portez des vêtements longs et utilisez des répulsifs." } }, { "@type": "Question", "name": "Comment se protéger contre le virus Zika ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les moustiques, portez des vêtements protecteurs et utilisez des répulsifs." } }, { "@type": "Question", "name": "Quelles précautions pour éviter les infections alimentaires ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Mangez des aliments bien cuits, évitez l'eau non traitée et lavez les fruits." } }, { "@type": "Question", "name": "Comment prévenir le choléra ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Buvez de l'eau potable, lavez-vous les mains et évitez les aliments crus dans les zones à risque." } }, { "@type": "Question", "name": "Quel traitement pour le paludisme ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement du paludisme inclut des antipaludiques comme la chloroquine ou l'artémisinine." } }, { "@type": "Question", "name": "Comment traiter la dengue ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement spécifique ; le repos et l'hydratation sont essentiels." } }, { "@type": "Question", "name": "Quel traitement pour l'infection à Zika ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement est symptomatique, avec repos, hydratation et médicaments pour la douleur." } }, { "@type": "Question", "name": "Comment traiter une infection alimentaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'hydratation et, si nécessaire, des antibiotiques pour les cas graves." } }, { "@type": "Question", "name": "Quel traitement pour le choléra ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Le choléra nécessite une réhydratation rapide et des antibiotiques dans les cas sévères." } }, { "@type": "Question", "name": "Quelles complications du paludisme ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'anémie, l'insuffisance rénale et le coma dans les cas graves." } }, { "@type": "Question", "name": "Quelles complications de la dengue ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La dengue peut entraîner des hémorragies, un choc et des défaillances organiques." } }, { "@type": "Question", "name": "Quelles complications de l'infection à Zika ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le Zika peut causer des malformations congénitales et des troubles neurologiques." } }, { "@type": "Question", "name": "Quelles complications des infections alimentaires ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure la déshydratation sévère et des infections systémiques." } }, { "@type": "Question", "name": "Quelles complications du choléra ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Le choléra peut entraîner une déshydratation sévère, un choc hypovolémique et la mort." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du paludisme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le voyage dans des zones endémiques et l'absence de prophylaxie." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de dengue ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Vivre ou voyager dans des zones tropicales et la présence de moustiques Aedes sont des risques." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le virus Zika ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des zones infectées et le contact avec des moustiques sont des facteurs clés." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les infections alimentaires ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Manger dans des lieux non hygiéniques et consommer de l'eau contaminée augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour le choléra ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Voyager dans des zones à risque, consommer de l'eau non potable et des aliments crus sont des risques." } } ] } ] }

Sources (7085 au total)

Systematic reviews on platelet transfusions: Is there unnecessary duplication of effort? A scoping review.

Platelet transfusions are used across multiple patient populations to prevent and correct bleeding. This scoping review aimed to map the currently available systematic reviews (SRs) and evidence-based... A systematic literature search was conducted in seven databases for SRs on effectiveness (including dose and timing, transfusion trigger and ratio to other blood products), production modalities and d... We identified 110 SRs. The majority focused on clinical effectiveness, including prophylactic or therapeutic transfusions compared to no platelet transfusion (34 SRs), prophylactic compared to therape... An interactive evidence map of SRs and evidence-based guidelines in the field of platelet transfusion has been developed and identified multiple reviews. This work serves as a tool for researchers loo...

The safety of ABO minor incompatible platelets transfusions using a rapid infuser.

Administering platelets through a rapid infuser is proven to be safe. However, the clinical significance of infusing ABO-incompatible platelets with red blood cells (RBCs) in a rapid infuser remains u... Seven in vitro studies were performed including five cases (type A RBCs and type O platelets) and two controls (type A RBCs and platelets). Anti-A titers were measured in platelet units. An RBC unit a... The post-mix DAT was positive for IgG in all test samples (5/5), and weakly positive for complement in 3/5. The changes in free Hb in test cases between measured and calculated post-mix spanned -2.2 t... Our study suggested that mixing ABO-incompatible platelets with RBCs in a rapid infuser does not induce in vitro hemolysis. These findings support the use of rapid infusers regardless of platelet comp...

Therapeutic Efficacy of Platelet Transfusion and Analysis of Influencing Factors in 364 patients.

The aims of this study were to observe the therapeutic effect of platelet (PLT) transfusion and to analyze influencing factors for the sake of providing useful clues for improving the efficacy of PLT ... Included in this study were patients who received PLT transfusion in the affiliated hospital of Nantong University. Patients' sex, age, height, weight, PLT transfusion status, and 20-24-h PLT count be... A total of 364 patients received 1,060 PLT transfusions, including 728 successful transfusions and 332 unsuccessful transfusions. When the patients were grouped according to different etiologies, sign... To reduce PTR, multiple factors should be considered comprehensively when PLT transfusion therapy is to be implemented in clinical practice. PLT antibody is the main immune factor causing PTR....

Platelet transfusion practice pattern before and after implementation of a local restrictive transfusion protocol in a neonatal intensive care unit.

Following the results of the PlaNeT-2 randomized controlled trial showing decreased morbidity and mortality in neonates transfused at a threshold of 25 versus 50 × 10... Prospective observational cohort chart-review study comparing all neonates consecutively admitted to the NICU during two 5-months periods: 2013 (before; N = 401) versus 2021 (after; N = 402). Possible... Mean (± standard deviation) gestational age and birth weight were 34.9 ± 4.2 weeks and 2.5 ± 1.0 kg, respectively. In 2021, 5.0% were platelet-transfused versus 9.2% in 2013 (p = .027). Platelet trans... Restrictive local transfusion thresholds in a NICU decreased the proportion of platelet-transfused neonates by 46% and reduced donor exposure in transfused patients....

Two-year outcomes following a randomised platelet transfusion trial in preterm infants.

Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia... Randomised clinical trial, enrolling from June 2011 to August 2017. Follow-up was complete by January 2020. Caregivers were not blinded; however, outcome assessors were blinded to treatment group.... 43 level II/III/IV neonatal intensive care units (NICUs) across UK, Netherlands and Ireland.... 660 infants born at less than 34 weeks' gestation with platelet counts less than 50×10... Infants were randomised to undergo a platelet transfusion at platelet count thresholds of 50×10... Our prespecified long-term follow-up outcome was a composite of death or neurodevelopmental impairment (developmental delay, cerebral palsy, seizure disorder, profound hearing or vision loss) at 2 yea... Follow-up data were available for 601 of 653 (92%) eligible participants. Of the 296 infants assigned to the higher threshold group, 147 (50%) died or survived with neurodevelopmental impairment, as c... Infants randomised to a higher platelet transfusion threshold of 50×10... ISRCTN87736839....

Aged versus fresh autologous platelet transfusion in a two-hit healthy volunteer model of transfusion-related acute lung injury.

Transfusion-related acute lung injury (TRALI) is a severe complication of blood transfusion that is thought of as a two-hit event: first the underlying patient condition (e.g., sepsis), and then the t... In a randomized controlled trial, 18 healthy male volunteers received a first hit of experimental endotoxemia (2 ng/kg lipopolysaccharide), and a second hit of fresh (2-day old) or aged (7-day old) au... All subjects reacted adequately to lipopolysaccharide infusion and satisfied SIRS criteria (increased pulse [>90/min] and temperature [>38°C]). There were no differences between the saline, fresh, and... In a human endotoxemia model of autologous platelet transfusion, with an adequate first hit and platelet storage lesion, transfusion of 7-day-old PC does not increase pulmonary inflammation compared w...

A randomized cross-over study of cryopreserved platelets in prophylactic transfusions of thrombocytopenic patients.

The short shelf-life of liquid-stored platelets (LP) at 20-24°C poses shortage and wastage challenges. Cryopreserved platelets have significantly extended shelf-life, and were safe and efficacious for... We performed a phase 1b/2a randomized cross-over study comparing the safety and efficacy of cryopreserved buffy coat-derived pooled platelets (CP) to LP in the prophylactic transfusions of thrombocyto... A total of 18 adults were randomly assigned 1:1 to CP and LP for their first thrombocytopenic period (TP) of up to 28-days. A total of 14 crossed over to the other platelet-arm for the second TP. Over... During shortages, CP may supplement LP in prophylactic transfusions of thrombocytopenic patients....